FDA approves Sagent's heparin vials

Twitter icon
Facebook icon
LinkedIn icon
e-mail icon
Google icon

The FDA has approved Sagent Pharmaceuticals’ nine presentations of heparin sodium injection, USP.

The company said its heparin is latex-free and features its proprietary PreventIV Measures packaging and labeling, which aids users in distinguishing between the nine presentations. The packaging and labeling features for heparin include the use of a color for total strength, drug name, concentration and fill volume and cartons printed on all sides.    

The Schaumburg, Ill.-based Sagent said it will launch the product immediately.